Pharmacologic mood destabilization: case vignettes.
Swann
Alan C
AC
Department of Psychiatry and Behavioral Sciences, University of Texas Health Science Center, Houston, TX, USA.
D000328:Adult; D000339:Affect / Q000187:drug effects*; D000927:Anticonvulsants / Q000009:adverse effects* / Q000627:therapeutic use; D000069445:Atomoxetine Hydrochloride; D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy; D001714:Bipolar Disorder / Q000139:chemically induced* / Q000175:diagnosis / Q000188:drug therapy; D000697:Central Nervous System Stimulants / Q000009:adverse effects* / Q000627:therapeutic use; D003866:Depressive Disorder / Q000188:drug therapy; D004305:Dose-Response Relationship, Drug; D019317:Evidence-Based Medicine; D005260:Female; D006801:Humans; D000077213:Lamotrigine; D008297:Male; D008875:Middle Aged; D010665:Phenylpropanolamine / Q000009:adverse effects* / Q000627:therapeutic use; D011437:Propylamines / Q000009:adverse effects* / Q000627:therapeutic use; D006255:Rhinitis, Allergic, Seasonal / Q000188:drug therapy; D014227:Triazines / Q000009:adverse effects* / Q000627:therapeutic use
D000927:Anticonvulsants; D000697:Central Nervous System Stimulants; D011437:Propylamines; D014227:Triazines; D010665:Phenylpropanolamine; D000069445:Atomoxetine Hydrochloride; D000077213:Lamotrigine